Recent concerns have prompted an official call for an investigation into potential conflicts of interest involving a top FDA official in the medical device industry, Dr. Jeffrey Shuren, and his wife’s legal activities. Dr. Shuren, who will retire from the Food and Drug Administration later this year, has faced scrutiny over his professional actions, which may have coincided with his wife Allison’s legal representation of medical device companies Shuren.
Christina Jewett reports that Representatives Anna Eshoo of California and Rosa DeLauro of Connecticut have officially called on the inspector general to look into these potential ethical conflicts. Both lawmakers, influential members of the key health and appropriations subcommittees, acted after revelations from an investigative report highlighted possible overlapping professional duties and personal interests within the Shuren family.
This investigation centers on Allison Shuren, who co-chairs the drug and medical device practice at a well-known Washington, D.C. law firm, Arnold & Porter, and her representation of companies that her husband’s agency directly regulates. The situation presents a complex landscape of intertwined professional responsibilities that could pose risks of bias or improper influence in regulatory practices.
The investigation aims to ensure transparency and integrity in the regulatory processes that govern critical medical devices such as pacemakers and even artificial ones, safeguarding public trust in the oversight conducted by the FDA.